PEOPLE - Iridex elects to the board:
This article was originally published in Clinica
Ophthalmology and dermatology laser systems manufacturer Iridex has elected Garret Garretson to its board of directors. The appointment increases the Mountain View, California-based firm's board to seven directors. Dr Garretson was most recently president and CEO of ClairVoyante Laboratories, and prior to this, served at Spectrian.
You may also be interested in...
Tensions between industry and the European Commission on the issue of health claims for botanical food supplements were aired on the second day of the BAH's High Level Conference on the Future of Medicines, with the EC saying the EU Green Deal is now higher up on its list of priorities for the foreseeable future.
Issues over supply and the use of a skinny label have the potential to take a toll on the market for the fish oil drug icosapent ethyl, one analyst has claimed in the wake of Hikma’s recent generic launch.
The German Bundestag has adopted the Unified Patent Court’s draft ratification bill with the necessary qualified majority.